SCHEMBL9853391

SCHEMBL9853391

CCCCn1c(=O)n(CCCCC(C)=O)c(=O)c2c1ncn2CC(C)=O

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 9/20 0.88
PDE4B Q07343 8/20 0.88
PDE4C Q08493 8/20 0.88
PDE4D Q08499 8/20 0.88
ADORA2A P29274 3/20 0.88
ADORA2B P29275 2/20 0.88
LMNA P02545 2/20 0.70
CYP1A2 P05177 2/20 0.70
NFKB1 P19838 2/20 0.70
ACHE P22303 2/20 0.70
PMP22 Q01453 2/20 0.70
ESR1 P03372 1/20 0.70
MAPT P10636 1/20 0.70
BLM P54132 1/20 0.70
RXFP1 Q9HBX9 2/20 0.59
TNF P01375 2/20 0.59
USP2 O75604 1/20 0.59
TSHR P16473 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
MAPK1 P28482 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10694108 0.94 PDE4A (0.91) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL10695543 0.94 PDE4A (0.91) PDE4APDE4BPDE4CPDE4DADORA2A
Denbufylline SCHEMBL127152 0.94 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DADORA2A
Denbufylline SCHEMBL7299526 0.94 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL10873386 0.93 PDE4A (0.77) PDE4APDE4BPDE4CPDE4DADORA2A
Denbufylline SCHEMBL11044404 0.93 PDE4A (0.97) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL7802893 0.92 PDE4A (0.83) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL10872056 0.92 PDE4A (0.95) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL7323464 0.91 PDE4A (0.93) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL11456819 0.89 PDE4A (0.77) PDE4APDE4BPDE4CPDE4DADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0421587-A2 Xanthine derivatives used in asthma Beecham Group p.l.c. (GB) 1991-04-10 EP claimed
US-4657910-A Treatment of cerebrovascular disorders and/or disorders associated with cerebral senility BEECHAM-WUELFING GMBH & CO. KG (DE) 1987-04-14 US claimed
EP-0195496-A2 Use of xanthines in the treatment of proliferative skin disease BEECHAM GROUP PLC (GB) 1986-09-24 EP claimed
EP-0042706-B1 XANTHINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND A PROCESS FOR THEIR PREPARATION BEECHAM - WUELFING GmbH & Co. KG (DE) 1985-12-27 EP claimed
US-4372959-A TREATMENT OF PERIPHERAL VASCULAR DISEASE BEECHAM-WULFING GMBH & CO. KG (DE) 1983-02-08 US claimed
EP-0042706-A2 Xanthine derivatives, pharmaceutical compositions containing them and a process for their preparation BEECHAM - WUELFING GmbH & Co. KG (DE) 1981-12-30 EP claimed
EP-0421587-A2 Xanthine derivatives used in asthma Beecham Group p.l.c. (GB) 1991-04-10 EP disclosed
EP-0195496-A2 Use of xanthines in the treatment of proliferative skin disease BEECHAM GROUP PLC (GB) 1986-09-24 EP disclosed
EP-0173039-A2 Use of xanthine and thioxanthine derivatives for the preparation of medicaments BEECHAM - WUELFING GmbH & Co. KG (DE) 1986-03-05 EP disclosed
EP-0042706-B1 XANTHINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND A PROCESS FOR THEIR PREPARATION BEECHAM - WUELFING GmbH & Co. KG (DE) 1985-12-27 EP disclosed
EP-0157098-A1 Xanthine derivatives, pharmaceuticals compositions containing them and a process for their preparation Beecham Wuelfing GmbH & Co KG (DE) 1985-10-09 EP disclosed
US-4372959-A TREATMENT OF PERIPHERAL VASCULAR DISEASE BEECHAM-WULFING GMBH & CO. KG (DE) 1983-02-08 US disclosed
EP-0042706-A2 Xanthine derivatives, pharmaceutical compositions containing them and a process for their preparation BEECHAM - WUELFING GmbH & Co. KG (DE) 1981-12-30 EP disclosed